
ComEd Launches EV Ambassador Program to Expand EV Adoption in Northern Illinois
CHICAGO--(BUSINESS WIRE)--To expand efforts to support customers considering making the switch to electric vehicles (EVs), ComEd today announced the launch of its new EV Ambassador Program, a community-driven initiative designed to expand education and awareness around EV adoption and benefits in northern Illinois. The program will launch with the introduction of three local partner organizations: Equiticity, Bronzeville Community Development Partnership and A Step Beyond NFP. EV Ambassadors through this program will engage directly with residents and local businesses through community events, presentations and pop-up EV demonstrations throughout the summer.
'Switching to an EV can come with a variety of benefits, including fuel cost savings and reduced environmental impact. We are committed to helping our customers reap the benefits of this transition and ensure they understand the resources available to them as they consider EV options,' said Melissa Washington, senior vice president of customer operations and strategic initiatives at ComEd. 'ComEd launched this new EV Ambassador program to better reach customers where they are, increase the visibility of our offerings and connect communities who will see the greatest benefits of EVs with the correct resources.'
The EV Ambassador Program is part of ComEd's broader Beneficial Electrification (BE) Plan, which provides customers with resources and financial rebates to support the transition to cleaner transportation. ComEd's BE funding launched in its 2023 BE Plan, and funding has been extended through 2028 with the recent approval of ComEd's second BE Plan. Through the new EV Ambassador initiative, ambassadors will interact with community members and businesses to connect them with ComEd rebate programs, EV Dealership network, EV Toolkit and more.
'I'm honored to serve as a ComEd EV Ambassador, and excited to spread the wealth of knowledge that empowers our communities to embrace cleaner energy, reduce our carbon footprint and build a brighter, healthier future for our city. Together, we can make meaningful change, one conversation, one home and one neighborhood at a time,' said Nicole Wheatly, Founder and Executive Director of A Step Beyond NFP.
'Bronzeville Community Development Partnership and JitneyEV are pleased to participate as ComEd EV Ambassadors. This program aligns with our mission of accelerating the EV transition, especially in historically underserved communities where health and air quality are negatively impacted by proximity to expressways and industrial corridors. One of the biggest barriers to EV adoption is lack of awareness about the economic and health benefits of EV transportation,' said William Davis, Executive Director at Bronzeville Community Development Partnership.
'Equiticity is pleased to partner with ComEd on their new EV Ambassador Program. We look forward to our work together to ensure Black and Brown neighborhoods are experiencing the range of benefits from increased adoption of electric transportation,' said Olatunji Oboi Reed, President and CEO of Equiticity.
Community members can meet with ComEd's EV Ambassadors and experience EV technology firsthand at a variety of events this summer including:
- Oak Park Farmer's Market: May 31
- Broadview Village Hall Community EV Presentation: May 31
- Rockford Community Market: June 5
- Heartland Alliance 'Vital Bridges' Community Event: June 13
- Transport Chicago 2025: June 13
- Park Forest EV Car Show: June 25
- Cars at Lincoln Commons: June 28
Additional events will be added to the EV Ambassador Program schedule throughout the year, and information can be found at ComEd.com/EV.
The Ambassador organizations were selected through a rigorous application and interview process to ensure that each represented organization would have a strong interest in sustainability and credibility in their respective communities. Each participating Ambassador organization will be awarded a small stipend for their participation in 2025 and ComEd hopes to continue this program in future years.
The launch of the ComEd EV Ambassador program builds on existing commitments from the utility to support EV adoption for its customers. In February, ComEd announced at least $100 million rebates available to customers in 2025 to help more customers take steps toward EV adoption. To reduce the cost barriers to EVs, the rebates cover three distinct programs: residential EV charger and installation costs, all-electric fleet vehicles and business and public sector make ready charging costs. To date, ComEd has awarded $30 million in rebates this year funding nearly 5,000 public and private EV charging ports (L2 and DC Fast Chargers) and incentivizing the lease or purchase of nearly 1,000 new and pre-owned electric fleet vehicles. A majority of the funds, 85% has been awarded to customers residing in, or primarily doing business in Equity Investment Eligible (EIEC) communities.
All of ComEd's EV programming puts equity front and center, with more than half of the total rebate funds reserved for low-income customers and equity-eligible communities, and the majority of community education and awareness events taking place in equity-eligible communities. For more information on EV resources and programs offered by ComEd, please visit ComEd.com/EV.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Protect nine household devices with this $16 app
The following content is brought to you by Mashable partners. If you buy a product featured here, we may earn an affiliate commission or other compensation. TL;DR: Protect up to nine devices for life with AdGuard, now just $16 with code FAMPLAN through July 20. The internet is full of distractions and worse. Between invasive ads, data trackers, phishing scams, and inappropriate content, your digital life (and your family's) deserves better online protection. AdGuard can help be there when you're not thinking about protection, and for a limited time, you can get lifetime access to the AdGuard Family Plan for just $15.97 (MSRP $169.99) when you use code FAMPLAN by July 20. AdGuard is more than your average ad blocker. It's a cross-platform privacy tool that cleans up your online experience across browsers and apps. It blocks pop-ups, autoplay videos, trackers, and even malicious links—keeping your browsing faster, cleaner, and safer. The Family Plan covers up to nine devices, so everyone in your household, from kids to grandparents, can enjoy safer browsing on their phones, tablets, or computers. AdGuard's parental control features let you filter out inappropriate or harmful websites, giving parents more peace of mind about what their kids can access. Plus, its malware and phishing protection adds an extra layer of defense against online threats. Whether you're working, streaming, or managing your kids' screen time, AdGuard helps the whole family stay safer online without recurring costs. Secure your devices and your privacy for life — Use code FAMPLAN to get AdGuard Family Plan for just $15.97 until July 20. StackSocial prices subject to change. Opens in a new window Credit: AdGuard AdGuard Family Plan: Lifetime Subscription $15.97 $169.99 Save $154.02 Get Deal
Yahoo
18 hours ago
- Yahoo
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, June 06, 2025--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 39,345 shares of the Company's common stock to four new employees (the "Inducement Grants") on June 5, 2025 (the "Grant Date"). The Inducement Grants have been granted pursuant to the Company's 2025 Inducement Plan (the "Plan"). The Inducement Grants were granted as an inducement material to these individuals entering into employment with Neurogene in accordance with Nasdaq Listing Rule 5635(c)(4). The Inducement Grants have an exercise price per share that is equal to the closing price of Neurogene's common stock on the Grant Date. The Inducement Grants will vest over four years, with 25 percent vesting on the first anniversary of the vesting commencement date and thereafter in equal portions upon the lapse of each three-month period over the following 36-month period, subject to the employee's continued employment with Neurogene through the applicable vesting dates. About Neurogene The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders. This includes selecting a delivery approach to maximize distribution to target tissues and designing products to maximize potency and purity for an optimized efficacy and safety profile. The Company's novel and proprietary EXACT™ transgene regulation platform technology allows for the delivery of therapeutic levels while limiting transgene toxicity associated with conventional gene therapy. Neurogene has constructed a state-of-the-art gene therapy manufacturing facility in Houston, Texas. CGMP production of NGN-401 was conducted in this facility and will support pivotal clinical development activities. For more information, visit View source version on Contacts Company Contact: Cara MayfieldVice President, Corporate Investor Contact: Melissa ForstArgot PartnersNeurogene@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 hours ago
- Yahoo
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, June 06, 2025--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 39,345 shares of the Company's common stock to four new employees (the "Inducement Grants") on June 5, 2025 (the "Grant Date"). The Inducement Grants have been granted pursuant to the Company's 2025 Inducement Plan (the "Plan"). The Inducement Grants were granted as an inducement material to these individuals entering into employment with Neurogene in accordance with Nasdaq Listing Rule 5635(c)(4). The Inducement Grants have an exercise price per share that is equal to the closing price of Neurogene's common stock on the Grant Date. The Inducement Grants will vest over four years, with 25 percent vesting on the first anniversary of the vesting commencement date and thereafter in equal portions upon the lapse of each three-month period over the following 36-month period, subject to the employee's continued employment with Neurogene through the applicable vesting dates. About Neurogene The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders. This includes selecting a delivery approach to maximize distribution to target tissues and designing products to maximize potency and purity for an optimized efficacy and safety profile. The Company's novel and proprietary EXACT™ transgene regulation platform technology allows for the delivery of therapeutic levels while limiting transgene toxicity associated with conventional gene therapy. Neurogene has constructed a state-of-the-art gene therapy manufacturing facility in Houston, Texas. CGMP production of NGN-401 was conducted in this facility and will support pivotal clinical development activities. For more information, visit View source version on Contacts Company Contact: Cara MayfieldVice President, Corporate Investor Contact: Melissa ForstArgot PartnersNeurogene@